PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.42
Similar ESG score to AFMD's 58.70. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
57.61
Environmental score 1.1-1.2x AFMD's 53.86. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
61.21
Similar social score to AFMD's 62.50. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
62.44
Similar governance score to AFMD's 59.75. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.